PM | Ticker Profile - Titan Protect

Philip Morris International

Consumer Staples · Tobacco · US

$178.29

Data:

✗ ETHICAL FAIL

UNKNOWN MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$266.5B

Total market value of the company

Trailing P/E

24.10

Premium valuation

Forward P/E

18.70

Based on estimated future earnings — lower means cheaper

Rev Growth

+9.1%

Year-over-year revenue change

Profit Margin

0.0%

How much profit the company keeps from each dollar of revenue

ROE

N/A

Return on equity — how efficiently it uses shareholder money

Analyst Target

$192.14

+8% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 14 analysts covering this stock

About Philip Morris International

Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.

https://www.pmi.com

Country: United States Employees: 84,900 Industry: Tobacco

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0%

Debt must be below 33% of total assets

Cash Ratio

0.0%

Interest-bearing cash below 33% of assets

Receivables

0.0%

Receivables below 49% of assets

Revenue Purity

0.0%

Non-compliant revenue below 5% — any excess requires purification

Valuation

Fair Value Est.

$183.00

What our model estimates this business is worth per share

Margin of Safety

2.6%

Slight discount to fair value

Rating

AVOID

Overall assessment combining ethics, valuation, and quality

Percentile

42.6th

Ranks in the top 57% of our 13,571 screened universe

Ethical Score

10.0

Valuation Score

67.0

Quality Score

35.0

Combined

37.6

Trading near fair value at $171 (estimated $183). Fails ethical screen (Business activity screen). Ranks better than 8% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

1.426

Excellent risk-adjusted returns

Kelly Fraction

0.1288

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

1.962

Returns exceed worst-case losses — strong risk profile

Annual Return

40.5%

Historical annualised return based on price data

Max Drawdown

-20.6%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.39

Very low correlation to market moves

52W High

$192.95

8% below the year high

52W Low

$142.11

25% above the year low

Avg Volume

4,968,150

Average daily shares traded — higher means easier to buy and sell

Short Ratio

3.4

Days it would take all short sellers to cover — higher means more crowded

Short % Float

1.1%

Low short interest — limited bearish positioning

Div Yield

344.0%

Annual dividend as a percentage of the share price

EPS (TTM)

$7.10

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

N/A

Current Ratio

0.98

Below 1 means short-term obligations exceed liquid assets — risk flag

Quick Ratio

0.45

Like current ratio but excludes inventory — stricter test

Gross Margin

67.3%

Revenue left after cost of goods — higher means pricing power

Operating Margin

36.0%

Profit from core operations before interest and tax

Free Cash Flow

$8.6B

Positive — the business generates more cash than it spends

Revenue (TTM)

$41.5B

Total revenue over the last 12 months

Net Income

$11.1B

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$210.00

Target Median

$192.14

Target Low

$168.00

Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

55

NEUTRAL

Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Politicians have been buying this name.

Date	Insider	Title	Shares	Value
2026-05-06	CALANTZOPOULOS ANDRE	Chairman of the Board	1,119	$190,152
2026-05-06	HARKER VICTORIA D	Director	1,119	$190,152
2026-05-06	GEISSLER WERNER	Director	1,119	$190,152
2026-05-06	HOOK LISA A.	Director	1,119	$190,152
2026-05-06	BOUGH BONIN	Director	1,119	$190,152
2026-05-06	COMBES MICHEL	Director	1,119	$190,152
2026-05-06	POLET ROBERT	Director	1,119	$190,152
2026-05-06	YANAI SHLOMO	Director	1,119	$190,152
2026-05-06	MORPARIA KALPANA	Director	1,119	$190,152
2026-02-20	DOBROWOLSKI REGINALDO	Officer	6,000	$1,100,880

Source: SEC Form 4 filings via public data. View all insider activity at

Insider Intelligence

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
2026-05-08	Bill Keating	Democrat	Purchase	1K–15K
2026-04-24	Ro Khanna	Democrat	Purchase	1K–15K
2026-04-13	Ro Khanna	Democrat	Purchase	1K–15K
2025-06-17	John Fetterman	Democrat	Purchase	1K–15K
2024-03-15	Tony Wied		buy	15000

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated:

Before you go